ID   U-2030 TG
AC   CVCL_M582
DR   Wikidata; Q54973544
RX   PubMed=3583453;
CC   Characteristics: Produces IgA lambda.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M581 ! U-2030
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
RX   PubMed=3583453; DOI=10.1002/ijc.2910390615;
RA   Jernberg-Wiklund, Helena
RA   Bjorklund, Gunilla
RA   Nilsson, Kenneth
RT   "Establishment of a new human myeloma cell line (U-2030) and selection
RT   of a HAT-sensitive subline.";
RL   Int. J. Cancer 39:745-751(1987).
//